Chih Lung Shen
Director/Board Member at MEDEON BIODESIGN, INC.
Profile
Chih Lung Shen is the founder of Allgenesis Biotherapeutics, Inc. He currently holds multiple director positions, including Independent Director at Medeon Biodesign, Inc. since 2015, Director at EirGenix, Inc. since 2021, Director at Noratech Pharmaceuticals, Inc., Director at Annji Pharmaceutical Co., Ltd.
since 2019, and Managing Member at Cheng Xin Venture Capital Group.
Previously, he served as an Independent Director at Lotus Pharmaceutical Co., Ltd.
from 2013 to 2014, Director at Mycenax Biotech, Inc., Director at Kiotek Corp., Non-Executive Director at ASLAN Pharmaceuticals Pte Ltd., Director at TWi Pharmaceuticals, Inc., Director at ARDIC Instruments Co., and Non-Executive Director at Aslan Pharmaceuticals Ltd.
from 2016 to 2018.
He also held positions as a Member-Supervisory Board at TWi Pharmaceuticals, Inc. from 2012 to 2014 and Member-Supervisory Board at TWi Biotechnology, Inc. Dr. Shen obtained a doctorate degree from the University of Wisconsin and an undergraduate degree from Tsinghua University.
Chih Lung Shen active positions
| Companies | Position | Start |
|---|---|---|
| MEDEON BIODESIGN, INC. | Director/Board Member | 2015-04-19 |
| EIRGENIX INC. | Director/Board Member | 2021-12-05 |
Cheng Xin Venture Capital Group
 Cheng Xin Venture Capital Group Investment ManagersFinance Cheng Xin Venture Capital Group (CXVCG) is a venture capital investment firm located in Taipei, Taiwan. Established in 1990, the firm manages a number of investment funds focusing on high technology and biotechnology firms. | Investment Committee Member | - |
| Noratech Pharmaceuticals, Inc. | Director/Board Member | - |
Annji Pharmaceutical Co., Ltd.
 Annji Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Annji Pharmaceutical Co., Ltd. operates as a drug development company that produces small molecules for neurology, dermatology and inflammatory disorders. The company was founded on December 15, 2014 and is headquartered in Taipei, Taiwan. | Director/Board Member | 2019-05-02 |
Former positions of Chih Lung Shen
| Companies | Position | End |
|---|---|---|
| ASLAN PHARMACEUTICALS LIMITED | Director/Board Member | 2018-10-29 |
| LOTUS PHARMACEUTICAL CO., LTD. | Director/Board Member | 2014-08-31 |
| TWI PHARMACEUTICALS INC | Director/Board Member | 2014-05-31 |
| MYCENAX BIOTECH INC. | Director/Board Member | - |
| ░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Chih Lung Shen
| University of Wisconsin | Doctorate Degree |
| Tsinghua University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 7 |
|---|---|
| MYCENAX BIOTECH INC. | Health Technology |
| LOTUS PHARMACEUTICAL CO., LTD. | Health Technology |
| MEDEON BIODESIGN, INC. | Electronic Technology |
| ASLAN PHARMACEUTICALS LIMITED | Health Technology |
| TWI BIOTECHNOLOGY, INC. | Health Technology |
| EIRGENIX INC. | Health Technology |
 | Health Technology |
| Private companies | 7 |
|---|---|
Cheng Xin Venture Capital Group
Cheng Xin Venture Capital Group Investment ManagersFinance Cheng Xin Venture Capital Group (CXVCG) is a venture capital investment firm located in Taipei, Taiwan. Established in 1990, the firm manages a number of investment funds focusing on high technology and biotechnology firms. | Finance |
Kiotek Corp.
 Kiotek Corp. BiotechnologyHealth Technology Kiotek Corp. researches, develops and manufactures chitosan based products. It offers biotechnological products such as chttins and chitosans that assist in weight loss. The company was founded in 1997 and is headquartered in Hsinchu, Taiwan. | Health Technology |
TWi Pharmaceuticals, Inc.
 TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
| ARDIC Instruments Co. | |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
Allgenesis Biotherapeutics, Inc.
 Allgenesis Biotherapeutics, Inc. BiotechnologyHealth Technology Allgenesis Biotherapeutics, Inc. is a Taiwanese clinical-stage biopharmaceutical company focused on researching and developing novel medicines for the treatment of eye diseases. The private company is based in Taipei, Taiwan. The company's current pipeline includes potential blockbuster drugs such as ag-73305 for the treatment of DME, NAMD, and other retinal diseases, as well as ag-80308 for dry eye disease. The company was founded by Chih Lung Shen and Chih Ming Chen. Madhu Cherukury has been the CEO of the company since 2014. | Health Technology |
| Noratech Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Chih Lung Shen
